发明名称 Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
摘要 Long acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of glatiramer are provided. In particular, the long acting pharmaceutical composition comprises a therapeutically effective amount of glatiramer acetate in depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot form is suitable for subcutaneous or intramuscular implantation or injection.
申请公布号 US8796226(B2) 申请公布日期 2014.08.05
申请号 US201013258808 申请日期 2010.08.19
申请人 Mapi Pharma Ltd. 发明人 Marom Ehud;Rubnov Shai
分类号 A61K38/16;A61K38/10;A61K38/02;A61K9/19;C07K14/00;A61K9/00;A61K9/16 主分类号 A61K38/16
代理机构 Rothwell, Figg, Ernst & Manbeck, P.C. 代理人 Rothwell, Figg, Ernst & Manbeck, P.C.
主权项 1. A long acting parenteral pharmaceutical composition comprising a therapeutically effective amount of a pharmaceutically acceptable salt of glatiramer, the composition being in a sustained release depot form which releases a therapeutically effective amount of the pharmaceutically acceptable salt of glatiramer over a period of about 1 week to about 6 months, the pharmaceutical composition further comprising at least one additional drug.
地址 Ness Ziona IL